A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China
Clinical trial NCT03430830 · COMPLETED
Trial details
- NCT number
- NCT03430830
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2018-04-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.